Zobrazeno 1 - 10
of 38
pro vyhledávání: '"David H. Regan"'
Autor:
Mark U. Rarick, Julia Bohlius, Alan E. Lichtin, Mark R. Somerfield, David Cella, David H. Regan, Charles L. Bennett, Jerome Seidenfeld, Karen L. Hagerty, Benjamin Djulbegovic, Matthew J. Goode, Ann A. Jakubowski, J. Douglas Rizzo
Publikováno v:
Journal of Clinical Oncology. 26:132-149
Purpose To update the American Society of Clinical Oncology/American Society of Hematology (ASCO/ASH) recommendations for the use of epoetin. The guideline was expanded to address use of darbepoetin and thromboembolic risk associated with these agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d9711b50f9d641336ec7d430c4391d1
https://doi.org/10.1200/jco.2007.14.3396
https://doi.org/10.1200/jco.2007.14.3396
Autor:
Alan E. Lichtin, David Cella, Charles L. Bennet, Ann A. Jakubowski, Julia Bohlius, Matthew J. Goode, David H. Regan, Douglas Rizzo, Mark U. Rarick, Benjamin Djullbegovic, Jerome Seidenfeld, Karen L. Hagerty, Mark R. Somerfield
Publikováno v:
Journal of Oncology Practice. 4:48-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41fe5dc08bacf22e9a4d5e4c824e7fc0
https://doi.org/10.1200/jop.0818502
https://doi.org/10.1200/jop.0818502
Autor:
George P. Browman, David Cella, Stephanie J. Lee, Michael S. Gordon, Alan E. Lichtin, Matthew J. Goode, Carole B. Miller, David H. Regan, Steven H. Woolf, Charles L. Bennett, Mark U. Rarick, Ann A. Jakubowski, Benjamin Djulbegovic, J. Douglas Rizzo, Jerome Seidenfeld
Publikováno v:
Blood. 100:2303-2320
ABSTRACT: Anemia resulting from cancer, or its treatment, is an important clinical problem increasingly treated with the recombinant hematopoietic growth factor erythropoietin. To address uncertainties regarding indications and efficacy, the American
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e15dc8a2a657603bff9d7b265489e2
https://doi.org/10.1182/blood-2002-06-1767
https://doi.org/10.1182/blood-2002-06-1767
Autor:
J. Douglas Rizzo, Mark R. Somerfield, Karen L. Hagerty, Jerome Seidenfeld, Julia Bohlius, Charles L. Bennett, David F. Cella, Benjamin Djulbegovic, Matthew J. Goode, Ann A. Jakubowski, Carole B. Miller, Mark U. Rarick, David H. Regan, Alan E. Lichtin
Publikováno v:
Journal of Clinical Oncology. 26:3098-3100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dbb1b7e6e0cbe03ef918ae8a61428bd
https://doi.org/10.1200/jco.2008.16.9086
https://doi.org/10.1200/jco.2008.16.9086
Autor:
Gary E. Raskob, Jeffrey S. Wasser, Indira Warrier, Alan E. Lichtin, JA Okerbloom, Louis M. Aledort, Victor S. Blanchette, James B. Bussel, John G. Kelton, David H. Regan, Douglas B. Cines, James N. George, P. J. Ballem, Robert McMillan, Steven H. Woolf
Publikováno v:
Blood. 88:3-40
DIOPATHIC thrombocytopenic purpura (ITP, also I known as primary immune thrombocytopenic purpura) is a hematologic disorder for which appropriate diagnostic and treatment strategies are uncertain. In 1994, the American Society of Hematology (ASH) est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::569d68d4ce2862a871029898914f19c5
https://doi.org/10.1182/blood.v88.1.3.bloodjournal8813
https://doi.org/10.1182/blood.v88.1.3.bloodjournal8813
Publikováno v:
Journal of Clinical Psychology. 49:777-789
Interleukin-1 (IL-1) bioassays were done on 208 serum samples drawn from 7 volunteers, over several hours at 5-minute intervals, before, during, and after a relaxation-related behavioral stimulus. Individuals showed up to a 267% increase (t[29] = 7.7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2f000c254b323ca00f0a6ac41450ae2
https://doi.org/10.1002/1097-4679(199311)49:6<777::aid-jclp2270490605>3.0.co
https://doi.org/10.1002/1097-4679(199311)49:6<777::aid-jclp2270490605>3.0.co
Autor:
J. Douglas Rizzo, Matthew J. Goode, David H. Regan, Jerome Seidenfeld, Charles L. Bennett, Jerry L. Spivak, Melissa C. Brouwers, Darren Evanchuk, Mark R. Somerfield, Ann A. Jakubowski, Julia Bohlius, Patricia Hurley, Murat O. Arcasoy
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(33)
Purpose To update American Society of Clinical Oncology/American Society of Hematology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer. Methods An Update Committee reviewed data published between January 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb4a02eb71c1fb2135d299f47f21a4d
https://pubmed.ncbi.nlm.nih.gov/20975064
https://pubmed.ncbi.nlm.nih.gov/20975064
Autor:
Ann A. Jakubowski, Murat O. Arcasoy, Darren Evanchuk, Charles L. Bennett, Mark R. Somerfield, J. Douglas Rizzo, Jerry L. Spivak, Matthew J. Goode, Patricia Hurley, Julia Bohlius, Melissa C. Brouwers, Jerome Seidenfeld, David H. Regan
Purpose: To update American Society of Hematology/American Society of Clinical Oncology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer. Methods: An Update Committee reviewed data published between January
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4c98d921d3e9afb8f9c525a1a86a151
Autor:
Mark R. Somerfield, Charles L. Bennett, Julia Bohlius, Ann A. Jakubowski, David Cella, Benjamin Djulbegovic, Karen L. Hagerty, Jerome Seidenfeld, David H. Regan, Mark U. Rarick, Matthew J. Goode, Alan E. Lichtin, J. Douglas Rizzo
Publikováno v:
Blood. 111(1)
Purpose: To update the American Society of Clinical Oncology/American Society of Hematology (ASCO/ASH) recommendations for the use of epoetin. The guideline was expanded to address use of darbepoetin and thromboembolic risk associated with these agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::629ef299e65590eda107a9b475d95ac9
https://pubmed.ncbi.nlm.nih.gov/17954703
https://pubmed.ncbi.nlm.nih.gov/17954703
Autor:
Tammy Roque, Edward Agura, Mary Lange, Douglas Orr, Pankaj Khandelwal, Robert G. Mennel, Kristi J. McIntyre, Michael W. Schuster, Leslie Garrison, Robert Kirby, Lewis Duncan, Stephen E. Jones, Nikolay V. Dimitrov, William J. Hyman, David H. Regan
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(10)
PURPOSE: To measure the effect of PIXY321 (granulocyte-macrophage colony-stimulating factor/interleukin-3 S. cerevisiae fusion protein) on the incidence, duration, and complications of neutropenia and thrombocytopenia after moderate-dose fluorouracil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9efabab332911c3d809451e762b7b9a1
https://pubmed.ncbi.nlm.nih.gov/10506596
https://pubmed.ncbi.nlm.nih.gov/10506596